CRDF News and Press, Cardiff Oncology Inc. From 05/02/24

Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...

Cardiff Oncology, Inc. (NASDAQ: CRDF) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 9.61% on the day to $4.46. Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients ...

- Management will hold a conference call on Thursday, May 2 at 4:30 p.m. ET/1:30 p.m. PT - SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a r...

RAS-mutated mCRC – In RAS-mutated mCRC, novel preclinical finding demonstrates onvansertib inhibits the tumor’s ability to adapt to hypoxia resulting in a significant decrease in both tumor vascularization and growth – – Enhanced clinic...

2024-03-11 09:30:53 ET Kidpik  ( PIK ) +281% . L.S. Starrett ( SCX ) +59% Enters Into a Merger Agreement With MiddleGround Capital to Become Private Company. TC BioPharm  ( TCBP ) +57% . Unusual Machines  ( UMAC ) +34% . A...

2024-03-08 19:37:17 ET Summary Cardiff Oncology is focused on developing a drug for colorectal cancer and pancreatic cancer, with promising early activity shown in colorectal cancer patients. The company is now focused on moving their drug to the first-line setting and has started...

SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced publications of five abstracts that will be presented in a poster session at...

2024-03-04 10:17:34 ET DENVER, Colo., Mar 04, 2024 ( 247marketnews.com )- Cardiff Oncology, Inc. (NASDAQ: CRDF ) reported, last week, its fourth quarter and full year 2023 financial results, and provided a business update, which we covered when it was trading at $2.26 in Thursday&#x...

A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 33.7% to $0.4825 on volume of 369,944,141 shares Jaguar Health Inc. (JAGX) rose 50.0% to $0.0885 on volume of 303,339,477 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 12.6% to $3.32 on ...

2024-03-04 06:51:00 ET 3 Tips for Making a Long Term Penny Stocks Portfolio Investing in penny stocks presents an attractive opportunity for those looking to diversify their investment portfolios with potentially high-reward options. Despite their low price point, penny stocks can offer...